Borosil Scientific Ltd
Since 1962, Borosil is into finest quality scientific and laboratory glassware, which is used in Quality Control in pharmaceutical industries, Food and Soil testing, Microbiology, and Biotechnology.[1]
- Market Cap ₹ 1,120 Cr.
- Current Price ₹ 126
- High / Low ₹ 181 / 96.6
- Stock P/E 25.2
- Book Value ₹ 49.6
- Dividend Yield 0.00 %
- ROCE 12.1 %
- ROE 9.52 %
- Face Value ₹ 1.00
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Stock is trading at 2.55 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 7.61% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Industrials Capital Goods Industrial Products Glass - Industrial
Part of BSE Industrials
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|
| 392 | 434 | 467 | 478 | |
| 345 | 381 | 405 | 412 | |
| Operating Profit | 47 | 53 | 62 | 66 |
| OPM % | 12% | 12% | 13% | 14% |
| 4 | 8 | 1 | 7 | |
| Interest | 3 | 2 | 1 | 1 |
| Depreciation | 16 | 18 | 19 | 19 |
| Profit before tax | 32 | 40 | 43 | 53 |
| Tax % | 26% | 34% | 19% | |
| 23 | 27 | 35 | 43 | |
| EPS in Rs | 2.65 | 3.01 | 3.89 | 4.85 |
| Dividend Payout % | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 85% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -10% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 8% |
| Last Year: | 10% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Equity Capital | 9 | 9 | 9 |
| Reserves | 367 | 395 | 432 |
| 18 | 14 | 9 | |
| 95 | 86 | 99 | |
| Total Liabilities | 488 | 504 | 549 |
| 192 | 187 | 189 | |
| CWIP | 1 | 1 | 9 |
| Investments | 0 | 105 | 122 |
| 295 | 210 | 229 | |
| Total Assets | 488 | 504 | 549 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| 30 | 120 | 43 | |
| -2 | -115 | -37 | |
| -16 | -3 | -6 | |
| Net Cash Flow | 12 | 1 | -0 |
| Free Cash Flow | 17 | 106 | 16 |
| CFO/OP | 97% | 249% | 93% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Debtor Days | 57 | 59 | 59 |
| Inventory Days | 244 | 218 | 226 |
| Days Payable | 102 | 79 | 93 |
| Cash Conversion Cycle | 200 | 199 | 192 |
| Working Capital Days | 165 | 86 | 179 |
| ROCE % | 10% | 12% |
Insights
In beta| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Number of channel partners partners |
|
||
| Number of exporting countries countries |
|||
| Number of SKUs SKUs |
|||
| Glass Ampoules manufacturing capacity Mn p.a. |
|||
| Laboratory glassware manufacturing capacity (Bharuch) units/day |
|||
| Market share in domestic laboratory glassware % |
|||
| Pharmaceutical share of scientific customer mix % |
|||
| Tubular Glass Vials manufacturing capacity Mn p.a. |
|||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
- Intimation of allotment of 4,475 equity shares against stock options exercised under the Company''s ESOP Scheme
-
Announcement under Regulation 30 (LODR)-Investor Presentation
- Investor Presentation on Company''s performance - Q1-FY 2027
- Unaudited Financial Results (Standalone & Consolidated) For The Quarter Ended June 30, 2026
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On August 03, 2026
- Board approved Q1 FY27 results on August 3, 2026 and amended ESOP schemes.
-
Board Meeting Intimation for Disclosure Under Regulation 29 Of The SEBI (LODR) Regulations, 2015 - Board Meeting Intimation
- Board meets August 3, 2026 to approve Q1 FY27 standalone and consolidated results.
Annual reports
Concalls
-
Aug 2026TranscriptAI SummaryPPT
-
May 2026TranscriptAI SummaryPPT
-
Feb 2026TranscriptAI SummaryPPT
-
Nov 2025TranscriptAI SummaryPPT
-
Aug 2025TranscriptAI SummaryPPT
-
May 2025TranscriptAI SummaryPPT
-
Feb 2025TranscriptAI SummaryPPT
-
Nov 2024TranscriptAI SummaryPPT
-
Aug 2024TranscriptAI SummaryPPT
Borosil Group[1]
The company is a part of Borosil group which is into glassware and laboratory products,
scientific & industrial glassware, consumer & kitchenware products, and solar glass products. Group comprises of:
1. Borosil Renewables Ltd
2. Borosil Ltd
3. Borosil Scientific Ltd